Japan· JP-3999429G2024
アバタセプト（遺伝子組換え）
A medicinal product containing アバタセプト（遺伝子組換え）, registered in Japan by ブリストル・マイヤーズ スクイブ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アバタセプト（遺伝子組換え）
- Manufacturer
- ブリストル・マイヤーズ スクイブ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
アバタセプト（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaORENCIABristol-Myers Squibb Pharma EEIG, Dublin
- FinlandOrenciaBristol-Myers Squibb Pharma EEIG
- BelgiumOrencia 125 mgBristol-Myers Squibb Pharma
- FranceORENCIA 125 mg, solution injectable en seringue préremplieBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- United KingdomOrencia 125mg/1ml solution for injection pre-filled syringesBristol-Myers Squibb Pharmaceuticals Ltd
- IrelandOrencia 125 mg solution for injection in pre-filled penBristol-Myers Squibb Pharma EEIG
- IcelandOrenciaBristol-Myers Squibb Pharma EEIG*
- SwedenORENCIA 125 mg Injektionsvätska, lösning i förfylld injektionspennaBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Orencia
- Liechtenstein · Orencia
- Norway · Orencia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0142dfa-7e60-4d87-b6c2-5a298de3b05d GET /v1/drugs/d0142dfa-7e60-4d87-b6c2-5a298de3b05d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１２５ｍｇ１ｍＬ１キット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999429G2024",
"category": "注射薬",
"price_yen": 19068,
"generic_name": "アバタセプト（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about アバタセプト（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.